Clinique Pasteur

The medical center is at the forefront of urology research, particularly focusing on Benign Prostate Hyperplasia (BPH). The institution is exploring innovative approaches to manage BPH, emphasizing the role of antibiotic treatment prior to endoscopic surgery. This research aims to redefine the standard care protocols by evaluating the necessity of antibiotics in reducing post-surgical urinary tract infections.

• Benign Prostate Hyperplasia Management
• Antibiotic Stewardship in Urology
• Post-Surgical Infection Control

Through its pioneering studies, the center contributes significantly to the understanding of BPH treatment, potentially influencing global guidelines and improving patient outcomes.

Specializing in oncology, the medical center is advancing the treatment of recurrent ovarian cancer. The focus is on evaluating the efficacy of olaparib maintenance therapy beyond disease progression compared to traditional platinum chemotherapy. This research is crucial in enhancing progression-free survival rates and optimizing therapeutic strategies for patients undergoing secondary cytoreductive surgery.

• Recurrent Ovarian Cancer Treatment
• Olaparib Maintenance Therapy
• Progression-Free Survival Enhancement

The center's work in this area is pivotal in shaping future treatment paradigms, offering hope for improved survival and quality of life for ovarian cancer patients.